A research project led by the Ineos Oxford Institute for antimicrobial research (IOI) to study the cause and impact of ...

Answer ALS, a large-scale research initiative headquartered in New Orleans and Washington, D.C., has announced the launch of ...

Kuwait's Ministry of Health signs agreements with five prestigious French hospitals, enhancing local healthcare through ...

Genethon is determined to bring GNT0004 to market for young patients and their families who are waiting for a therapeutic ...

He was immediately referred to the CU Anschutz Medical Campus where he met with Janet Kukreja, MD, director of urologic oncology at the CU Cancer Center and UCHealth University of ...

Harvard T.H. Chan School of Public Health suggests combining GLP-1 weight-loss medication with tailored nutrition and ...

More than three of every five liver cancer cases in the world can be prevented by addressing risk factors, such as hepatitis, alcohol habits and non-alcoholic fatty liver conditions, according to an ...

UC Health Monday opened the McGrath Outpatient Pavilion at its Hillcrest location, the first major milestone in redevelopment.

A toxic fungus killed ten scientists working on a tomb in Poland, and it’s believed the same spore killed those who excavated ...

The ongoing Phase I/IIa study (NCT04725331) is a multicenter, open label, dose-escalation study evaluating BT-001 as a single agent and in combination with MSD’s (Merck & Co., Inc., Rahway, NJ, USA) ...

Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma  Approval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction ...